PMC:7441788 / 418-674 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T2","span":{"begin":146,"end":154},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma67180"}],"text":"oxychloroquine (HCQ), are being repurposed as treatment for COVID-19. CQ/HCQ were shown to prevent receptor recognition by coronaviruses, inhibit endosome acidification, which interferes with membrane fusion, and exhibit immunomodulatory activity. These mu"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T9","span":{"begin":60,"end":68},"obj":"Disease"}],"attributes":[{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"oxychloroquine (HCQ), are being repurposed as treatment for COVID-19. CQ/HCQ were shown to prevent receptor recognition by coronaviruses, inhibit endosome acidification, which interferes with membrane fusion, and exhibit immunomodulatory activity. These mu"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1","span":{"begin":192,"end":200},"obj":"http://purl.obolibrary.org/obo/UBERON_0000158"},{"id":"T2","span":{"begin":238,"end":246},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"oxychloroquine (HCQ), are being repurposed as treatment for COVID-19. CQ/HCQ were shown to prevent receptor recognition by coronaviruses, inhibit endosome acidification, which interferes with membrane fusion, and exhibit immunomodulatory activity. These mu"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T9","span":{"begin":70,"end":72},"obj":"Chemical"}],"attributes":[{"id":"A9","pred":"chebi_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"}],"text":"oxychloroquine (HCQ), are being repurposed as treatment for COVID-19. CQ/HCQ were shown to prevent receptor recognition by coronaviruses, inhibit endosome acidification, which interferes with membrane fusion, and exhibit immunomodulatory activity. These mu"}

{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T6","span":{"begin":70,"end":72},"obj":"Chemical"}],"attributes":[{"id":"A6","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"}],"text":"oxychloroquine (HCQ), are being repurposed as treatment for COVID-19. CQ/HCQ were shown to prevent receptor recognition by coronaviruses, inhibit endosome acidification, which interferes with membrane fusion, and exhibit immunomodulatory activity. These mu"}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T7","span":{"begin":60,"end":68},"obj":"Species"}],"attributes":[{"id":"A7","pred":"ncbi_taxonomy_id","subj":"T7","obj":"NCBItxid:2697049"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"oxychloroquine (HCQ), are being repurposed as treatment for COVID-19. CQ/HCQ were shown to prevent receptor recognition by coronaviruses, inhibit endosome acidification, which interferes with membrane fusion, and exhibit immunomodulatory activity. These mu"}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T10","span":{"begin":70,"end":247},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"oxychloroquine (HCQ), are being repurposed as treatment for COVID-19. CQ/HCQ were shown to prevent receptor recognition by coronaviruses, inhibit endosome acidification, which interferes with membrane fusion, and exhibit immunomodulatory activity. These mu"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"43","span":{"begin":123,"end":136},"obj":"Species"},{"id":"51","span":{"begin":16,"end":19},"obj":"Chemical"},{"id":"66","span":{"begin":60,"end":68},"obj":"Disease"}],"attributes":[{"id":"A43","pred":"pubann:denotes","subj":"43","obj":"Tax:11118"},{"id":"A51","pred":"pubann:denotes","subj":"51","obj":"MESH:D006886"},{"id":"A66","pred":"pubann:denotes","subj":"66","obj":"MESH:C000657245"}],"text":"oxychloroquine (HCQ), are being repurposed as treatment for COVID-19. CQ/HCQ were shown to prevent receptor recognition by coronaviruses, inhibit endosome acidification, which interferes with membrane fusion, and exhibit immunomodulatory activity. These mu"}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T2","span":{"begin":146,"end":154},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma67180"}],"text":"oxychloroquine (HCQ), are being repurposed as treatment for COVID-19. CQ/HCQ were shown to prevent receptor recognition by coronaviruses, inhibit endosome acidification, which interferes with membrane fusion, and exhibit immunomodulatory activity. These mu"}

{"project":"LitCovid-sample-PD-GO-BP-0","denotations":[{"id":"T1","span":{"begin":155,"end":168},"obj":"http://purl.obolibrary.org/obo/GO_0045851"},{"id":"T2","span":{"begin":192,"end":207},"obj":"http://purl.obolibrary.org/obo/GO_0061025"}],"text":"oxychloroquine (HCQ), are being repurposed as treatment for COVID-19. CQ/HCQ were shown to prevent receptor recognition by coronaviruses, inhibit endosome acidification, which interferes with membrane fusion, and exhibit immunomodulatory activity. These mu"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T7","span":{"begin":60,"end":68},"obj":"Disease"}],"attributes":[{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"oxychloroquine (HCQ), are being repurposed as treatment for COVID-19. CQ/HCQ were shown to prevent receptor recognition by coronaviruses, inhibit endosome acidification, which interferes with membrane fusion, and exhibit immunomodulatory activity. These mu"}

{"project":"LitCovid-sample-GO-BP","denotations":[{"id":"T1","span":{"begin":155,"end":168},"obj":"http://purl.obolibrary.org/obo/GO_0045851"},{"id":"T2","span":{"begin":192,"end":207},"obj":"http://purl.obolibrary.org/obo/GO_0061025"}],"text":"oxychloroquine (HCQ), are being repurposed as treatment for COVID-19. CQ/HCQ were shown to prevent receptor recognition by coronaviruses, inhibit endosome acidification, which interferes with membrane fusion, and exhibit immunomodulatory activity. These mu"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T1","span":{"begin":155,"end":168},"obj":"http://purl.obolibrary.org/obo/GO_0045851"},{"id":"T2","span":{"begin":192,"end":207},"obj":"http://purl.obolibrary.org/obo/GO_0061025"}],"text":"oxychloroquine (HCQ), are being repurposed as treatment for COVID-19. CQ/HCQ were shown to prevent receptor recognition by coronaviruses, inhibit endosome acidification, which interferes with membrane fusion, and exhibit immunomodulatory activity. These mu"}

{"project":"LitCovid-PubTator","denotations":[{"id":"43","span":{"begin":123,"end":136},"obj":"Species"},{"id":"51","span":{"begin":16,"end":19},"obj":"Chemical"},{"id":"66","span":{"begin":60,"end":68},"obj":"Disease"}],"attributes":[{"id":"A43","pred":"tao:has_database_id","subj":"43","obj":"Tax:11118"},{"id":"A51","pred":"tao:has_database_id","subj":"51","obj":"MESH:D006886"},{"id":"A66","pred":"tao:has_database_id","subj":"66","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"oxychloroquine (HCQ), are being repurposed as treatment for COVID-19. CQ/HCQ were shown to prevent receptor recognition by coronaviruses, inhibit endosome acidification, which interferes with membrane fusion, and exhibit immunomodulatory activity. These mu"}

{"project":"LitCovid-sentences","denotations":[{"id":"T10","span":{"begin":70,"end":247},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"oxychloroquine (HCQ), are being repurposed as treatment for COVID-19. CQ/HCQ were shown to prevent receptor recognition by coronaviruses, inhibit endosome acidification, which interferes with membrane fusion, and exhibit immunomodulatory activity. These mu"}